🇺🇸 FDA

Company profile · Sponsor

Jazz

Jazz Pharmaceuticals Ireland Limited

JAZZ · NYSE pharma DUBLIN, GB
Pipeline
24
Drugs
11
Patents
8

Quick answer

Jazz (JAZZ) is a pharma company. headquartered in DUBLIN, GB. listed on NYSE. NovaPharmaNews links 24 pipeline programs, 11 drugs, and 8 patents to this profile..

Company facts

Ticker JAZZ
Exchange NYSE
Company type pharma
Headquarters DUBLIN, GB
SEC CIK 0001232524

Pipeline (24)

Search pipeline →

  1. Atezolizumab

    Jazz

    Small-Cell Lung Cancer

    phase 3 small molecule active

    1 trial

  2. Brincidofovir

    Jazz

    Adenovirus Infection

    phase 3 small molecule completed

    1 trial

  3. Brincidofovir

    Jazz

    CMV

    phase 3 small molecule completed

    1 trial

  4. Brincidofovir

    Jazz

    Double-stranded DNA Virus

    phase 3 small molecule completed

    1 trial

  5. Brincidofovir

    Jazz

    Cytomegalovirus Disease

    phase 3 small molecule terminated

    2 trials

  6. CPX-351

    Jazz

    High Risk Acute Myeloid Leukemia

    phase 3 small molecule completed

    1 trial

  7. Cannabidiol (CBD)

    Jazz

    Clinical High Risk for Psychosis (CHR)

    phase 3 small molecule active

    1 trial

  8. Cytarabine

    Jazz

    Acute Myeloid Leukemia

    phase 3 small molecule active

    1 trial

  9. Defibrotide

    Jazz

    Veno-occlusive Disease

    phase 3 small molecule completed

    2 trials

  10. Defibrotide

    Jazz

    Hepatic Veno-Occlusive Disease

    phase 3 small molecule completed

    2 trials

  11. Defibrotide

    Jazz

    Severe Hepatic Veno-Occlusive Disease

    phase 3 small molecule completed

    1 trial

  12. Dociparstat

    Jazz

    Acute Myeloid Leukemia

    phase 3 small molecule terminated

    1 trial

  13. Dociparstat sodium

    Jazz

    Coronavirus Disease 2019 (COVID-19)

    phase 3 small molecule terminated

    1 trial

  14. Dordaviprone (ONC201)

    Jazz

    H3 K27M

    phase 3 small molecule active

    1 trial

  15. Everolimus

    Jazz

    Diffuse Intrinsic Pontine Glioma

    phase 3 small molecule active

    1 trial

  16. GW-1000-02

    Jazz

    Multiple Sclerosis

    phase 3 small molecule completed

    4 trials

  17. GW-1000-02

    Jazz

    Pain

    phase 3 small molecule completed

    3 trials

  18. GWP42003-P

    Jazz

    Rett Syndrome

    phase 3 small molecule terminated

    2 trials

  19. GWP42003-P

    Jazz

    Infantile Spasms

    phase 3 small molecule completed

    2 trials

  20. GWP42003-P

    Jazz

    Seizures Associated With EMAS

    phase 3 small molecule terminated

    1 trial

  21. GWP42003-P

    Jazz

    Epilepsy

    phase 3 small molecule completed

    5 trials

  22. GWP42003-P

    Jazz

    Seizure in Participants With Tuberous Sclerosis Complex

    phase 3 small molecule terminated

    1 trial

  23. GWP42003-P

    Jazz

    Tuberous Sclerosis Complex

    phase 3 small molecule completed

    2 trials

  24. GWP42003-P 20 mg/kg/Day Dose

    Jazz

    Epilepsy

    phase 3 small molecule completed

    3 trials

Drugs (11)

Search drugs →

  1. asparaginase erwinia chrysanthemi (recombinant)-rywn

    RYLAZE

    INTRAMUSCULAR approved

  2. calcium oxybate

    XYWAV

    ORAL approved

  3. cannabidiol

    EPIDYOLEX

    ORAL approved

    N03AX

  4. clozapine

    CLOZAPINE

    ORAL approved

  5. crisantaspase

    ENRYLAZE

    L01XX02

  6. daunorubicin

    VYXEOS LIPOSOMAL (PREVIOUSLY VYXEOS)

    L01XY01

  7. defibrotide sodium

    DEFITELIO

    INTRAVENOUS approved

  8. fluvoxamine maleate

    FLUVOXAMINE MALEATE

    ORAL approved

  9. lurbinectedin

    ZEPZELCA

    INTRAVENOUS approved

    L01XX69

  10. zanidatamab

    ZIIHERA

    L01FD07

  11. zanidatamab-hrii

    ZIIHERA

    INJECTION approved

Patents (8)

Search patents →

  1. US 12427160

    Use of cannabinoids in the treatment of epilepsy

    Expires Mon Sep 25 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 12403136

    Cannabinoid derivatives as pharmaceutically active compounds and methods of preparation thereof

    Expires Mon Aug 28 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 12396963

    Cannabidiol-type cannabinoid compound

    Expires Mon Aug 21 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 12383512

    Cannabidiol-type cannabinoid compound

    Expires Mon Aug 07 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 12383567

    Use of cannabinoids in the treatment of epilepsy

    Expires Mon Aug 07 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 12364670

    Cannabidiol-type cannabinoid compound

    Expires Mon Jul 17 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 12357586

    Use of the phytocannabinoid cannabidiol (CBD) in combination with a standard anti-epileptic drug (SAED) in the treatment of epilepsy

    Expires Mon Jul 10 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 12350253

    Use of cannabinoids in the treatment of dyskinesia associated with parkinson's disease

    Expires Mon Jul 03 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is Jazz?

Jazz (JAZZ) is a pharma company. headquartered in DUBLIN, GB. listed on NYSE. NovaPharmaNews links 24 pipeline programs, 11 drugs, and 8 patents to this profile..

What pipeline programs does Jazz sponsor?

We track 24 ClinicalTrials.gov-linked programs for Jazz, including Atezolizumab and 23 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does Jazz company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.